Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
uniQure BV (QURE) PT Raised to $94 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Array BioPharma (ARRY) to Neutral
-
Fintech firm Pagaya issuing second $100 million asset-backed security
-
Pagaya Announces Second-Ever $100 Million ABS Fully-Managed By AI
-
Cantor Fitzgerald Reiterates Overweight Rating on Amarin Corporation (AMRN)
-
After-Hours Movers 07/01: (VERU) (OCX)
-
Cantor Fitzgerald Starts Veru, Inc. (VERU) at Overweight
-
Chiasma (CHMA) OPTIMAL Trial Data Sets Stage For Positive NDR - Cantor
-
Cantor Fitzgerald Starts PagSeguro (PAGS) at Overweight
-
Cantor Fitzgerald Starts StoneCo Ltd. (STNE) at Overweight
-
Cantor Fitzgerald Downgrades Arrowhead Research (ARWR) to Neutral
-
HealthEquity, Inc (HQY) PT Raised to $95 at Cantor Fitzgerald Following WageWorks Deal
-
Change Healthcare Inc. (CHNG) Prices 42.857M Share IPO at $13/Sh; Announces Concurrent Offering of Tangible Equity Units
-
Change Healthcare Inc. Prices IPO and Concurrent Offering of Tangible Equity Units
-
Global Blood Therapeutics (GBT) prices public offering of 3.38M shares of its common stock for gross proceeds of approximately $200 million
-
Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $87 at Cantor Fitzgerald; 'More Scarcity Value, Cash, and Pipeline Visibility'
-
Global Blood Therapeutics (GBT) to sell approximately $200 million in shares of common stock
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
-
Aldeyra Therapeutics (ALDX) Phase 3 Miss Amounts to $2/sh In Value - Cantor
-
Pre-Open Movers 06/25: (AGN) (PHUN) (PYX) (GRUB) (ALDX) (ABBV) (BHF) (AKRX) (more)
-
AGN/ABBV Deal Good for Pharma Space - Cantor Fitzgerald
-
Pfizer (PFE) Faces a High Hurdle This Friday to Appear Competitive with Sarepta (SRPT) - Cantor
-
UPDATE: Cantor Fitzgerald Starts Cellular Biomedicine Group (CBMG) at Overweight
-
After-Hours Movers 06/24: (ALDX) (GNFT) (USNA) Higher; (CNAT) (GMDA) (KRYS) (more...)
-
Cantor Fitzgerald Starts Rockwell Medical Technologies (RMTI) at Overweight
-
Krystal Biotech (KRYS) PT Nearly Doubled to $67 at Cantor Fitzgerald
-
Northern Dynasty Announces Closing of US$5.0 Million Bought Deal
-
Cantor Fitzgerald Resumes Cameco Corp. (CCO:CN) (CCJ) at Buy
-
HMS Holdings (HMSY) Sell-Off 'Overdone' - Cantor Fitzgerald
-
Pre-Open Movers 06/21: (AXGT) (MBIO) (OCUL) (WORK) (ANAB) (LKSD) (PTN) (BYND)
-
Cantor Fitzgerald Downgrades Ted Baker Plc. (TED:LN) (TBAKF) to Neutral
-
After-Hours Movers 06/20: (MBIO) (MEET) (TLRY) Higher; (LKSD) (KFY) (INVH) (more...)
-
UPDATE: Cantor Fitzgerald Starts Mustang Bio (MBIO) at Overweight
-
Freddie Mac Prices $435 Million Multifamily KG-Deal, K-G01
-
Northern Dynasty Minerals (NAK) Announces $5.0 Million Bought Deal and Concurrent Up to $1.5 Million Private Placement
-
Northern Dynasty Announces US$5.0 Million Bought Deal and Concurrent Up to US$1.5 Million Private Placement
-
Biohaven (BHVN) Prices 6.977M Shares Common Offering at $43/Sh
-
Biohaven Announces Pricing Of $300 Million Public Offering Of Common Shares
-
Cantor Fitzgerald Starts Paycom Software (PAYC) at Neutral
-
Cantor Fitzgerald Starts Paylocity Holding (PCTY) at Overweight
-
Cantor Fitzgerald Starts Upwork Inc. (UPWK) at Overweight
-
Rockwell Medical Technologies (RMTI) Prices 5.83M Share Common Stock Offering at $3/Share
-
Nevakar Enters $50 Million Product Financing Agreement with NovaQuest Capital for Continued Development of Injectable Products
-
Rockwell Medical Announces Pricing of $17.5 Million Public Offering of Common Stock
-
Rockwell Medical Technologies (RMTI) Commences Public Offering of Common Stock
-
Rockwell Medical Announces Proposed Public Offering of Common Stock
-
Contura Announces Completion of Successful Refinancing Through $561.8 Million Term Loan Credit Facility
-
bluebird bio (BLUE) PT Raised to $124 at Cantor Fitzgerald
-
Amarin (AMRN) Vascepa RXs Outpace Industry as of 06/07 - Cantor Fitzgerald

